Literature DB >> 7744402

P24 antigen detection, viral isolation, DNA-PCR and in vitro antibody production for the diagnosis of HIV-1 latent infection in heterosexual women at high risk for HIV-1 infection.

M Di Stefano1, J R Fiore, M Chironna, G Buccoliero, C Romanelli, L La Grasta, M Quarto, G Angarano, G Pastore.   

Abstract

INTRODUCTION: The report of the existence of at-risk seronegative subjects, latently infected with HIV-1 and producing "in vitro" HIV-1 specific antibodies, prompted the authors to evaluate extensively twenty-five heterosexual HIV-1 seronegative women at high risk for HIV-1 infection.
MATERIAL AND METHODS: The capability of peripheral blood mononuclear cells from such subjects to produce "in vitro" HIV-1 specific antibodies after pokeweed-mitogen stimulation, was studied. Silent HIV-1 infection was investigated by HIV-1 DNA PCR, viral isolation and serum p24 Ag detection at entry and after 6 and 12 months.
RESULTS: Three seroconversions took place within 12 months, but no HIV-1 infections were found in the absence of detectable serum anti HIV-1 antibodies, even in subjects who apparently produced such antibodies in vitro. The antibodies produced in vitro by the seronegative women studied appeared of narrow specificity, reacting mainly with gp 160/120 envelope glycoproteins.
CONCLUSIONS: A strong concordance was found between the serological status and the other markers for HIV-1 infection, suggesting that the phenomenon of HIV-1 "latent infection" is a very rare event, if it occurs at all. Seronegative women sexually exposed to the virus may produce in vitro anti HIV-1 antibodies of narrow specificity in the absence of other signs of infection and this phenomenon might be related to an anamnestic response to the virus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744402      PMCID: PMC1195468          DOI: 10.1136/sti.71.2.123

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  14 in total

1.  Duration of human immunodeficiency virus infection before detection of antibody.

Authors:  C R Horsburgh; C Y Ou; J Jason; S D Holmberg; I M Longini; C Schable; K H Mayer; A R Lifson; G Schochetman; J W Ward
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

2.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.

Authors:  C Y Ou; S Kwok; S W Mitchell; D H Mack; J J Sninsky; J W Krebs; P Feorino; D Warfield; G Schochetman
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

3.  Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.

Authors:  D T Imagawa; M H Lee; S M Wolinsky; K Sano; F Morales; S Kwok; J J Sninsky; P G Nishanian; J Giorgi; J L Fahey
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

4.  Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals.

Authors:  T Jehuda-Cohen; B A Slade; J D Powell; F Villinger; B De; T M Folks; H M McClure; K W Sell; A Ahmed-Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  DNA amplification of HIV-1 in seropositive individuals and in seronegative at-risk individuals.

Authors:  M Mariotti; J J Lefrère; B Noel; F Ferrer-Le-Coeur; D Vittecoq; R Girot; C Bosser; A M Couroucé; C Salmon; P Rouger
Journal:  AIDS       Date:  1990-07       Impact factor: 4.177

6.  Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers.

Authors:  J Albert; E M Fenyö
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

7.  Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men.

Authors:  S M Wolinsky; C R Rinaldo; S Kwok; J J Sninsky; P Gupta; D Imagawa; H Farzadegan; L P Jacobson; K S Grovit; M H Lee
Journal:  Ann Intern Med       Date:  1989-12-15       Impact factor: 25.391

8.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

Authors:  M Clerici; J V Giorgi; C C Chou; V K Gudeman; J A Zack; P Gupta; H N Ho; P G Nishanian; J A Berzofsky; G M Shearer
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

9.  Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.

Authors:  A Ranki; S L Valle; M Krohn; J Antonen; J P Allain; M Leuther; G Franchini; K Krohn
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

10.  Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study.

Authors:  H Farzadegan; M A Polis; S M Wolinsky; C R Rinaldo; J J Sninsky; S Kwok; R L Griffith; R A Kaslow; J P Phair; B F Polk
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.